China Startup Injects CRISPR Therapy into Human Brain for the First Time
In a groundbreaking medical first, Shanghai-based HuidaGene Therapeutics has administered a CRISPR-based therapy directly into the brain of a 9-year-old boy with MECP2...
© 2023 The Foundation for Bioethics in Technology A 501(c)(3) Non-Profit Corporation.